Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-04-01 Sale |
2024-04-03 4:05 pm |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $13.59 | $135,939 | 80,000 (Direct) |
View |
2024-02-01 Purchase |
2024-02-05 5:02 pm |
Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director |
2,481,350 | $12.09 | $29,999,522 | 6,485,420 (Indirect) |
View |
2024-01-26 Sale |
2024-01-30 5:03 pm |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $11.14 | $111,364 | 189,200 (Direct) |
View |
2023-12-21 Purchase |
2023-12-22 2:51 pm |
Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director |
740,000 | $6.2 | $4,588,000 | 4,004,070 (Indirect) |
View |
2023-10-16 Purchase |
2023-10-18 4:11 pm |
Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director |
1,074,608 | $6.514 | $6,999,997 | 4,490,113 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-21 Option Award |
2025-03-25 4:07 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Milne Jill C. CEO and President |
761,000 | $0 | 761,000 (Direct) |
View |
2025-03-21 Option Award |
2025-03-25 4:07 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer |
262,500 | $0 | 262,500 (Direct) |
View |
2025-03-21 Option Award |
2025-03-25 4:06 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
2025-03-21 Option Award |
2025-03-25 4:06 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer |
262,500 | $0 | 262,500 (Direct) |
View |
2025-03-21 Option Award |
2025-03-25 4:05 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Clauser Noah Chief Financial Officer |
262,500 | $0 | 262,500 (Direct) |
View |
2025-03-21 Option Award |
2025-03-25 4:05 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
262,500 | $0 | 262,500 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 4:07 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
14,100 | $0 | 14,100 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 4:07 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | Beck Joanne T. Director |
14,100 | $0 | 14,100 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 4:06 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | Violin Jonathan Director |
14,100 | $0 | 14,100 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 4:06 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | Callori Fred Director |
14,100 | $0 | 14,100 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 4:06 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | KISHBAUCH MICHAEL D Director |
14,100 | $0 | 14,100 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 4:05 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
14,100 | $0 | 14,100 (Direct) |
View |
2024-06-05 Option Award |
2024-06-06 4:05 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | BATE KENNETH Director |
14,100 | $0 | 14,100 (Direct) |
View |
2024-04-08 Option Award |
2024-04-09 08:11 am |
N/A 2034-04-07 |
Astria Therapeutics Inc. | ATXS | AGARWAL SUNIL Director |
28,200 | $0 | 28,200 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 4:05 pm |
N/A 2032-07-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $0 | 80,000 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 4:05 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $3.87 | 80,000 (Direct) |
View |
2024-02-08 Option Award |
2024-02-12 4:06 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2024-02-08 Option Award |
2024-02-12 4:06 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Milne Jill C. CEO and President |
534,600 | $0 | 534,600 (Direct) |
View |
2024-02-08 Option Award |
2024-02-12 4:05 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2024-02-08 Option Award |
2024-02-12 4:05 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2024-02-08 Option Award |
2024-02-12 4:05 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2024-02-08 Option Award |
2024-02-12 4:05 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Clauser Noah Chief Financial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2024-01-26 Exercise |
2024-01-30 5:03 pm |
N/A 2032-07-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $0 | 189,200 (Direct) |
View |
2024-01-26 Exercise |
2024-01-30 5:03 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $3.87 | 189,200 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:08 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Milne Jill C. CEO and President |
275,000 | $0 | 275,000 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:08 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer |
60,000 | $0 | 60,000 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:07 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:07 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:06 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | KISHBAUCH MICHAEL D Director |
14,100 | $0 | 14,100 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:06 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
14,100 | $0 | 14,100 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:06 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | Violin Jonathan Director |
14,100 | $0 | 14,100 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:05 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
14,100 | $0 | 14,100 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:04 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | Callori Fred Director |
14,100 | $0 | 14,100 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:04 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:03 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Clauser Noah Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:02 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | Beck Joanne T. Director |
14,100 | $0 | 14,100 (Direct) |
View |
2023-06-02 Option Award |
2023-06-06 08:00 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | BATE KENNETH Director |
14,100 | $0 | 14,100 (Direct) |
View |
2023-04-17 Option Award |
2023-04-19 08:10 am |
N/A 2033-04-16 |
Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer |
20,000 | $0 | 20,000 (Direct) |
View |